Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 238,263,033 papers from all fields of science
Search
Sign In
Create Free Account
TS 108
Known as:
TAS-108
, TAS108
, TS-108
A synthetic, antiestrogenic steroidal compound with potential antitumor activity. TAS-108 binds to and inhibits estrogenic receptor alpha (ERa…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
3 relations
Broader (1)
Estradiol
Narrower (1)
SR 16234
analogs & derivatives
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
A phase II, randomized, open-label, dose-finding study of TAS-108, a novel steroidal antiestrogen, administered orally in postmenopausal women with advanced or metastatic breast cancer.
H. Iwata
,
H. Inaji
,
T. Nakayama
,
N. Yamamoto
,
S. Noguchi
,
T. Ikeda
2009
Corpus ID: 71448796
CTRC-AACR San Antonio Breast Cancer Symposium: 2008 Abstracts Abstract #2132 Background: A phase II study was conducted to…
Expand
2001
2001
Phase I study of the novel oral steroidal antiestrogenic agent TAS-108, ascending single dose, safety, tolerance, and pharmacokinetic parameters in healthy postmenopausal women
J. Kuritani
,
M. Abdelhameed
,
+6 authors
A. Buzdar
2001
Corpus ID: 79758912
1999
1999
TS-108 Advanced Ceramic Matrix Composites and Silicon Nitride Materials for Gas Turbine Applications(Session D-7 Materials)
J. Garnier
,
P. Gray
,
D. Foley
1999
Corpus ID: 136794029